TY - JOUR
T1 - On the specific molecular configuration of neurotoxic aliphatic hexacarbon compounds causing central-peripheral distal axonopathy
AU - Spencer, Peter S.
AU - Bischoff, Monica C.
AU - Schaumburg, Herbert H.
PY - 1978/4
Y1 - 1978/4
N2 - A total of 56 young rats were fed 10 different hydrocarbon derivatives to determine the molecular configuration required for the production of nervous system disease of the type characterized by giant axonal degeneration in the distal regions of long and large, central and peripheral nerve fibers (central-peripheral distal axonopathy). For periods up to 14 weeks, animals drank ad libitum aqueous solutions containing 0.5% 2-heptanone, 0.5% 3,5-heptanedione, 0.5% 2,5-hexanedione, 0.5% 2,5-hexanediol, 0.5% 2,4-hexanedione, 0.5% 2,3-hexanedione, 0.5% 1,6-hexanediol, 0.5% 1,4-butanediol, 0.05, 0.1, or 0.25% glutaraldehyde, and 0.5 or 1% acetone. Animals treated with 2,5-hexanedione or 2,5-hexanediol failed to gain weight normally and slowly developed hindlimb weakness typical of a symmetrical peripheral neuropathy. Pathological examination of these animals revealed giant axonal swelling and secondary myelin changes in the distal regions of (1) the spino-cerebellar tracts in the cerebellar vermis and medulla oblongata, (2) the dorsal columns of the cervical, thoracic, and upper lumbar spinal cord, and (3) the sciatic, tibial, and plantar nerves. These characteristic clinical and pathological features of central-peripheral distal axonopathy failed to develop in the other groups of rats.
AB - A total of 56 young rats were fed 10 different hydrocarbon derivatives to determine the molecular configuration required for the production of nervous system disease of the type characterized by giant axonal degeneration in the distal regions of long and large, central and peripheral nerve fibers (central-peripheral distal axonopathy). For periods up to 14 weeks, animals drank ad libitum aqueous solutions containing 0.5% 2-heptanone, 0.5% 3,5-heptanedione, 0.5% 2,5-hexanedione, 0.5% 2,5-hexanediol, 0.5% 2,4-hexanedione, 0.5% 2,3-hexanedione, 0.5% 1,6-hexanediol, 0.5% 1,4-butanediol, 0.05, 0.1, or 0.25% glutaraldehyde, and 0.5 or 1% acetone. Animals treated with 2,5-hexanedione or 2,5-hexanediol failed to gain weight normally and slowly developed hindlimb weakness typical of a symmetrical peripheral neuropathy. Pathological examination of these animals revealed giant axonal swelling and secondary myelin changes in the distal regions of (1) the spino-cerebellar tracts in the cerebellar vermis and medulla oblongata, (2) the dorsal columns of the cervical, thoracic, and upper lumbar spinal cord, and (3) the sciatic, tibial, and plantar nerves. These characteristic clinical and pathological features of central-peripheral distal axonopathy failed to develop in the other groups of rats.
UR - http://www.scopus.com/inward/record.url?scp=0018194601&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0018194601&partnerID=8YFLogxK
U2 - 10.1016/0041-008X(78)90280-6
DO - 10.1016/0041-008X(78)90280-6
M3 - Article
C2 - 675688
AN - SCOPUS:0018194601
SN - 0041-008X
VL - 44
SP - 17
EP - 28
JO - Toxicology and Applied Pharmacology
JF - Toxicology and Applied Pharmacology
IS - 1
ER -